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The phenolic compounds of olives leaves and olive oils in the Mediterranean diet have been associated with a reduced incidence of heart disease.
Accordingly, antioxidant-rich diets may prevent the deleterious effects of oxidative metabolism by scavenging free radicals, thus inhibiting oxidation and delaying atherosclerosis. The process involves phospholipase C activation and arachidonic acid metabolism, and is thought to reduce hydrogen peroxide (H 2 O 2 ). In our study, an extract of Olea europaea L. leaves was used. The active phenolic compounds in this extract are part of the secoiridoid family, known for their capacity to scavenge H 2 O 2 . The results from this study will help to improve our understanding of effects of polyphenol antioxidants in olive leaf extract on platelet function.
Methods
Full blood examination (FBE), platelet aggregation, and ATP release were performed on samples from fasting, normal, healthy male subjects. Platelet function at increasing concentrations of oleuropein was investigated through measures of platelet aggregation and ATP release from activated platelets.
Conclusions
Olive leaf polyphenols derived from Olea europaea L. leaves inhibited in vitro platelet activation in healthy, non-smoking males. Further bioavailability studies need to be undertaken to determine the in vivo effect of extract on platelet function and to validate the present results.
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BACKGROUND
Olive leaves and olive oils in the Mediterranean diet have been the focus of many epidemiological studies and have been shown to reduce the incidence of heart disease [1] , [2] and [3] . Adherence to the traditional Mediterranean diet is associated with a significant reduction in total mortality [4] . For example, Estruch etal [5] found that compared with a low-fat diet, Mediterranean diets supplemented with olive oil or nuts have beneficial effects on cardiovascular risk factors. The Lyon Diet Heart Study tested a Mediterranean-type diet over long term and suggested that a comprehensive strategy to decrease cardiovascular morbidity and mortality should include primarily a cardio protective diet [6] .
The flavonoid polyphenols in olive are natural anti-oxidants, that have a host of health beneficial effects [7] . Hydroxytyrosol and tyrosol are some of the many phenol compounds in olives that contribute to bitter taste, astringency, and resistance to oxidation [8] , [9] and [10] . The active phenolic compounds in the olive leaf extract are part of the secoiridoid family, known for their capacity to scavenge H 2 O 2 [11] . Pignatelli et al. (1998) demonstrated that following stimulation by collagen, there is a burst of hydrogen peroxide (H 2 O 2 ) in the process of platelet activation [12] . H 2 O 2 activates the enzyme phospholipase C, which brings about arachidonic acid metabolism and platelet aggregation.
There is a growing interest in the use of natural antioxidants as bioactive components in food, and such foods have been termed "functional foods" [13] .
Due to their ability to scavenge reactive oxygen species (ROS), antioxidants are capable of inhibiting the process of low-density lipoprotein (LDL) cholesterol oxidation subsequently decreasing the risk of cardiovascular diseases [14] . Although oxidation of LDL can be prevented by the addition of synthetic antioxidants, greater attention is now focused on natural antioxidants because of their better safety compared to that of synthetic compounds [15] . The protective effects of these diets, which are rich in fruits and vegetables, against CHD and certain cancers have been attributed partly to the antioxidants found within them, particularly to polyphenols [13] .
In the current study, we used extract of Olea europaea L. leaves to determine the effect of olive leaf extract on platelet function in healthy human subjects.
METHODS AND MATERIALS

Subjects
Following approval by the RMIT University Human Research Ethics Committee, 11 healthy male volunteers between the ages of 18 to 54 years were recruited for this study. All subjects provided written informed consent to undertake the study.
Criteria for subject recruitment for the study included male, non-smoking, and healthy, with no history of cardiovascular disease or diabetes. Subjects were screened via means of a questionnaire, which requested information regarding level of physical activity, medical history, diet and use of aspirintype products, non-steroidal anti-inflammatory drugs, blood pressure and other drugs. During the testing phase, subjects were screened for aspirin intake via platelet aggregation response to the agonist, Arachidonic Acid.
Subjects were requested not to vary their habitual diet for the duration of the study. Subjects were required to complete a food record (diary) by food frequency questionnaire over a 7-day period. Diaries were analysed to monitor their intake of polyphenol rich food such as omega-3 polyunsaturated fatty acid rich foods, alcohol and cocoa products and to confirm study participants were not consuming antioxidant supplements. Subjects on medication, antioxidant supplements, and who had high dietary intakes of alcohol, seafood and cocoa products were also excluded from the study.
This study did not involve any additional dietary supplement intake.
Study design
A randomised single blinded study involving 11 healthy male volunteers was conducted in the Division of Laboratory Medicine, School of Medical Sciences, RMIT University. Subjects were overnight fasted before blood collection.
Whole blood, collected on two occasions at weekly intervals, was first screened for baseline platelet count (PLT) and mean platelet volume (MPV) before analysis with and without the in vitro addition of commercially available olive leaf extract (Olive Leaf Australia Pty. Ltd., QLD). The extract was diluted to produce various concentrations, and the amount of platelet aggregation induced at each concentration was investigated. The optimal dose was determined from the dose response curves constructed.
Olive leaf extract
The product Olive Leaf Extract was provided by Olive Leaf Australia Pty. Ltd., QLD. Previous composition investigation studies by the company have shown it to be 98% pure leaf extract of Olea europaea L. leaves. The product was stated to contain 5.40 mg/mL of oleuropein as its active ingredient. The actual product used was dark brown fluid with no solvents. It contained 50% waterextracted olive leaf extract (from fresh Olea europaea leaves) and 50% vegetable glycerine. The product was aqueous and could therefore be added directly to the blood.
Blood collection
A total of 22 mL of venous blood per volunteer was collected by a registered nurse at RMIT Health Services (Bundoora campus) using a tourniquet and 21-gauge Vacuettes© (Greiner bio-one GmbH, Kremsmünster, Austria). Blood was collected into 2mL tri-potassium ethylene diamine tetra-acetic acid (EDTA) (1.8 mg/mL), and 4 mL tri-sodium citrate (3.8%) tubes (Greiner bioone GmbH, Kremsmünster, Austria). The EDTA tubes were collected before the tri-sodium citrate tubes to avoid the risk of collecting platelets activated by venipuncture. Care was taken to ensure minimal specimen handling and agitation.
Full blood examination
EDTA anti-coagulated whole blood was analysed for PLT and MPV parameters using the Beckman Coulter A 
Sample preparation
Five volume-per-volume (v/v) concentrations of olive leaf extract were added to the blood, i.e. 0.1%, 0.3%, 0.5%, 0.7%, and 1.0% (Table 1 ). The concentrations of oleuropein from the extract were calculated to be 5.4 µg/mL, 16.2 µg/mL, 27.0 µg/mL, 37.8 µg/mL, and 54.0 µg/mL respectively. W hole blood without additives (containing 0% v/v olive extract or 0 µg/mL oleuropein) was used as a control and baseline measurement.
Platelet aggregation
The appropriate volume of olive leaf extract was added to the blood in cuvettes (Chrono-Log Corporation, Philadelphia, PA, USA) and incubated at 37°C ± 1.0 for 30 minutes. Siliconised stir bars (Chrono-Log Corporation, Philadelphia, PA, USA) were then added, and the samples were diluted 1:1 with pre-warmed 0.9% (w/v) saline (NaCl, BDH AnalaR, MERCK, Pty.
Limited, VIC). The samples were then placed inside the heating block testing wells of the aggregometer and the respective electrodes were immersed into samples for 2 minutes at 37°C ± 1.0 to ensure stability before analysis.
Platelet aggregation was recorded for 6 min. These investigations were carried out within 2 hr post venipuncture.
Statistics
Statistical analyses were performed using Microsoft® Excel 2000 (Microsoft Corporation, Redmond, WA, USA) and SPSS® version 12.0 (SPSS Inc., Chicago, IL, USA); a significance level of P<0.05 was applied. Analysis of variance (ANOVA) adjusted with Sidak simultaneous tests using SPSS® were performed to find significant differences between the concentrations of olive leaf extract tested. One-way ANOVA using Microsoft® Excel 2000 was applied for results from ATP release curve.
RESULTS
Subjects
Baseline FBE results on 11 subjects showed PLT count of 214 ± 34 x 10 9 /L and MPV of 8.0 ± 0.8 fl. All parameters fell within normal reference ranges. All subjects had avoided aspirin as normal platelet aggregation curves were obtained using arachidonic acid as an agonist.
Whole blood platelet aggregation
Platelet aggregation fell in a dose-dependent fashion with a steep fall between Karantonis et al reported that platelet-activating factor (PAF) antagonists in olive oil exert significant antiatherosclerotic activity in rabbits [17] . Both these studies (Petroni and Karantonis) used platelet rich plasma, whereas the current investigation used whole blood. As previously mentioned platelet analysis by the whole blood impedance method decreases the processing * and handling time of the specimen, thereby preserving its integrity, and is ultimately a better indication of platelet activity in situ.
Previous studies have demonstrated that oleuropein and hydroxytyrosol, due to their capacity to scavenge H 2 O 2 , inhibited the respiratory burst of human neutrophils elicited by phorbol 12-myristate 13-acetate (PMA) in a dosedependant fashion [18] . Hence, while the mechanism of action whereby these polyphenols are capable of inhibiting platelet function is not fully understood. It is hypothesized that this is due to their ability to scavenge H 2 O 2 , which is produced during the arachidonic acid metabolism cascade, which leads to platelet aggregation [12] .
This in vitro study does not take into account several variables such as absorption and metabolism of the supplement. There is insufficient data in the literature to fully understand the bioavailability of polyphenols such as oleuropein, hydroxytyrosol and tyrosol, which are found in olive leaf extract. It is known that oleuropein is poorly absorbed due to its large size and planar configuration [19] . It has however been hypothesized that since oleuropein is a glycoside, it could probably access a glucose transporter like a sodiumdependent glucose transporter (SGLT1) found on the epithelial cells of the small intestine, permitting its entry into the cells. Conversely, Hollman et al. postulated that the absorption of the quercetin glycoside, (a similar polyphenolic), involved active sugar transporters [20] . Gee and co-workers also showed that polyphenols are capable of interacting with SGLT1, adding further support to this theory [21] .
Although oleuropein is the only active ingredient found in the olive leaf extract used in this study, reports in the literature indicate that oleuropein is not the only phenolic found in Olea europaea L. leaves. Benavente-García et al.
quantified the various polyphenols found in Olea europaea L. leaves and reported that oleuropein was found to be the largest fraction. Other polyphenols like hydroxytyrosol, caffeic acid, luteolin and rutin were also isolated from the leaves [22] . The flava-3-nol catechin was also found in olive leaf extract. Data from our laboratory demonstrated that catechin is capable of inhibiting platelet function because of its antioxidant activity [23] .
Hydroxytyrosol, caffeic acid, luteolin and rutin are also established to have antioxidant activity and H 2 O 2 scavenging properties [24] . Polyphenols also display a synergic behaviour in mixed form, as occurs in olive leaf extract with a high content of oleuropein and other active polyphenols [22] , [24] , [25] and [26] . Therefore, the observed platelet inhibition could be attributed to a synergistic effect of the various polyphenols, as opposed to oleuropein alone.
For this reason, oleuropein concentrations were not reported in the dose response curves. The investigations involving this particular olive leaf extract can therefore only be considered a primary but valuable study. Further work is required for a profile on all the polyphenols found in this olive leaf extract.
The results of present study will need to be validated with in vivo evaluation of platelet activation such as urinary thromboxane B2 excretion and evaluation of oxidative stress markers such as isoprostanes (derived from the non enzymatic peroxidation of arachidonic acid) to provide insight into the mechanisms responsible for the inhibition of platelet function by polyphenols.
In conclusion, we demonstrate that polyphenols from olive leaf extract significantly inhibited platelet aggregation in vitro, possibly via their H 2 O 2 scavenging properties. This has important benefits for the food industry as the antiplatelet effects in olive leaves may offer a degree of protection from thrombosis and other cardiovascular diseases. Follow up in vivo studies will be undertaken to validate the results of current study and to establish the bioavailability of these polyphenols. These polyphenols could also be purified and concentrated followed by further studies on platelet aggregation to see their pure effect in vitro and in vivo. 
